StockWatch
·
Pharmaceuticals
Board Meeting26 Oct 2026, 07:11 pm

Hikal Ltd Board Meeting on Nov 3, 2026 for Q2 FY27 Results

AI Summary

Hikal Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda for this meeting is to consider, approve, and take on record the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026.

Key Highlights

  • Board meeting scheduled for November 3, 2026.
  • To consider standalone and consolidated financial results.
  • Covers the second quarter and half year ended September 30, 2026.
  • Unaudited financial results will be reviewed.